BUY MBP PORACTANT ALFA CUROSURF 240MG/3ML VIAL BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Medicine name: Poractant alfa
Medicine class: Pulmonary surfactant (natural surfactant replacement therapy)

I would like to explain your medicine called poractant alfa in clear and detailed terms so you understand why poractant alfa is used, how poractant alfa works in the body, how poractant alfa is given, and what to expect during and after treatment. Poractant alfa is a life-saving medicine commonly used in newborn and neonatal care and must always be given by trained healthcare professionals.

Poractant alfa is used to treat or prevent Respiratory Distress Syndrome (RDS) in premature or low-birth-weight babies. RDS occurs when a baby?s lungs do not produce enough natural surfactant, a substance that keeps the air sacs in the lungs open. Without enough surfactant, the lungs collapse easily, making breathing very difficult.

Poractant alfa works by replacing the missing natural surfactant in the lungs. It reduces surface tension inside the air sacs (alveoli), allowing them to stay open during breathing. This improves oxygen exchange, reduces the effort needed to breathe, and supports proper lung function. Poractant alfa helps the lungs work more effectively and reduces the risk of lung injury.

Poractant alfa is derived from natural porcine (pig) lung surfactant and closely mimics the surfactant naturally produced in the human body. Because of this, poractant alfa is highly effective and well tolerated.

Poractant alfa is given directly into the lungs through a breathing tube (endotracheal tube). It is administered by trained neonatal or critical care professionals in a hospital or neonatal intensive care unit (NICU). The medicine is given in small doses, usually while the baby is on assisted ventilation or continuous positive airway pressure (CPAP).

The dose of poractant alfa is calculated carefully based on the baby?s body weight. Some babies may need more than one dose depending on their response and clinical condition.

During administration of poractant alfa, the healthcare team closely monitors the baby?s heart rate, oxygen levels, breathing pattern, and blood pressure. Improvements in oxygenation often occur quickly after dosing.

Common short-term effects during or shortly after administration may include:
? Temporary changes in oxygen levels
? Brief slowing of the heart rate
? Mild airway obstruction from the liquid during administration

These effects are usually short-lived and are carefully managed by trained staff.

After receiving poractant alfa, many babies show improved breathing, reduced oxygen requirements, and better lung expansion. Mechanical ventilation settings may need adjustment as lung function improves.

Poractant alfa is generally very well tolerated. Serious side effects are uncommon when it is given correctly. However, the medical team will continuously monitor the baby for any signs of complications.

There is no known long-term harm associated with poractant alfa when used appropriately. In fact, it significantly reduces the risk of serious lung injury, air leaks, and complications related to respiratory distress in premature infants.

Poractant alfa does not replace the need for ongoing respiratory support in some babies, but it significantly improves survival and long-term lung outcomes.

Parents may notice improvement in breathing within minutes to hours after treatment, although recovery varies depending on gestational age and overall health.

There are no known interactions between poractant alfa and breast milk or routine neonatal medications.

In summary, poractant alfa is a critical, life-saving medicine used to treat respiratory distress in newborns by replacing missing lung surfactant. It helps improve breathing, oxygen delivery, and overall lung function. Safe and effective use of poractant alfa depends on expert administration, close monitoring, and supportive neonatal care. If you have questions or concerns about poractant alfa, your healthcare team can provide reassurance and explain how your baby is responding to treatment.